Plunkett Research Online: Hansa Medical

HANSA MEDICAL (HNSBF:GREY) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Hansa Medical AB is a biopharmaceutical company which develops novel immunomodulatory enzymes for transplantation and acute autoimmune diseases. The firm's pipeline of preclinical assets includes Ides, NiceR, Endos, and Enze, HBP-assay. The company is focused on research, development, and commercial.....



Hansa Medical
Ticker: HNSBF
Exchange: GREY
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 46 46165670
Fax: 46 46127775
Address: Scheelevägen 22
Lund, 220 63 Sweden

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing
ContactsDescription

Hansa Medical AB is a biopharmaceutical company which develops novel immunomodulatory enzymes for transplantation and acute autoimmune diseases. The firm's pipeline of preclinical assets includes Ides, NiceR, Endos, and Enze, HBP-assay. The company is focused on research, development, and commercial.....See More See More

Auditor: KPMG AB
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201620152014201320122011
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: